TY - JOUR
T1 - Spatiotemporal SERT expression in cortical map development
AU - Chen, Xiaoning
AU - Petit, Emilie I.
AU - Dobrenis, Kostantin
AU - Sze, Ji Ying
N1 - Funding Information:
This work was supported by grants from National Institute of Health to J.Y.S ( MH098290 , MH083982 , MH105839 ) and Rose F. Kennedy Intellectual and Developmental Disabilities Research Center ( P30 NIHHD71593 ).
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/9/1
Y1 - 2016/9/1
N2 - The cerebral cortex is organized into morphologically distinct areas that provide biological frameworks underlying perception, cognition, and behavior. Profiling mouse and human cortical transcriptomes have revealed temporal-specific differential gene expression modules in distinct neocortical areas during cortical map establishment. However, the biological roles of spatiotemporal gene expression in cortical patterning and how cortical topographic gene expression is regulated are largely unknown. Here, we characterize temporal- and spatial-defined expression of serotonin (5-HT) transporter (SERT) in glutamatergic neurons during sensory map development in mice. SERT is transiently expressed in glutamatergic thalamic neurons projecting to sensory cortices and in pyramidal neurons in the prefrontal cortex (PFC) and hippocampus (HPC) during the period that lays down the basic functional neural circuits. We previously identified that knockout of SERT in the thalamic neurons blocks 5-HT uptake by their thalamocortical axons, resulting in excessive 5-HT signaling that impairs sensory map architecture. In contrast, here we show that selective SERT knockout in the PFC and HPC neurons does not perturb sensory map patterning. These data suggest that transient SERT expression in specific glutamatergic neurons provides area-specific instructions for cortical map patterning. Hence, genetic and pharmacological manipulations of this SERT function could illuminate the fundamental genetic programming of cortex-specific maps and biological roles of temporal-specific cortical topographic gene expression in normal development and mental disorders.
AB - The cerebral cortex is organized into morphologically distinct areas that provide biological frameworks underlying perception, cognition, and behavior. Profiling mouse and human cortical transcriptomes have revealed temporal-specific differential gene expression modules in distinct neocortical areas during cortical map establishment. However, the biological roles of spatiotemporal gene expression in cortical patterning and how cortical topographic gene expression is regulated are largely unknown. Here, we characterize temporal- and spatial-defined expression of serotonin (5-HT) transporter (SERT) in glutamatergic neurons during sensory map development in mice. SERT is transiently expressed in glutamatergic thalamic neurons projecting to sensory cortices and in pyramidal neurons in the prefrontal cortex (PFC) and hippocampus (HPC) during the period that lays down the basic functional neural circuits. We previously identified that knockout of SERT in the thalamic neurons blocks 5-HT uptake by their thalamocortical axons, resulting in excessive 5-HT signaling that impairs sensory map architecture. In contrast, here we show that selective SERT knockout in the PFC and HPC neurons does not perturb sensory map patterning. These data suggest that transient SERT expression in specific glutamatergic neurons provides area-specific instructions for cortical map patterning. Hence, genetic and pharmacological manipulations of this SERT function could illuminate the fundamental genetic programming of cortex-specific maps and biological roles of temporal-specific cortical topographic gene expression in normal development and mental disorders.
KW - Cortical map architecture
KW - SERT conditional knockout mice
KW - Serotonin (5-HT)-absorbing neurons
KW - Serotonin transporter (SERT)
KW - Spatiotemporal gene expression
UR - http://www.scopus.com/inward/record.url?scp=84979520460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979520460&partnerID=8YFLogxK
U2 - 10.1016/j.neuint.2016.05.010
DO - 10.1016/j.neuint.2016.05.010
M3 - Article
C2 - 27282696
AN - SCOPUS:84979520460
SN - 0197-0186
VL - 98
SP - 129
EP - 137
JO - Neurochemistry International
JF - Neurochemistry International
ER -